Company / Interest Expense
Processa Pharmaceuticals, Inc. Interest Expense History
FY2013-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$281.1K
FY2021
5-year range
-$109.7K / $315.3K
FY2017-FY2021
Trend
+19.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $315,304 to $281,122 over the past 6 years.
Based on SEC 10-K filings.
$281,122 in FY2021 with a 5-year CAGR of +3.6%.
Improved from $315,304 to $281,122 over the past 6 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2021, interest expense increased 19.3% year-over-year.
- Peak interest expense was recorded in FY2015.
- Lowest interest expense in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $281.1K | +19.3% |
| FY2016 | $235.6K | -25.3% |
| FY2015 | $315.3K | +387.4% |
| FY2014 | -$109.7K | +35.7% |
| FY2013 | -$170.7K | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026